Jin Zhe, Jia Baoxing, Tan Ludong, Liu Yahui
Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Oncol Lett. 2019 Jul;18(1):314-320. doi: 10.3892/ol.2019.10280. Epub 2019 Apr 24.
MicroRNAs, considered as a promising focus for the treatment of tumors, are key regulators of a large number of genes. The aim of the present study was to investigate the biological functions of microRNA (miR)-330-3p in liver cancer as it had been identified previously that miR-330-3p was deregulated in liver cancer. In order to identify the function of miR-330-3p in liver cancer, the expression of miR-330-3p was determined in liver cancer tissues and adjacent non-tumor tissues using reverse transcription-quantitative polymerase chain reaction analysis. To elucidate the function of miR-330-3p in liver cancer, miR-330-3p was overexpressed using mimic transfection. Cell migration was inhibited by miR-330-3p in liver cancer cells. The miRNA target prediction databases were used to identify potential target genes of miR-330-3p in liver cancer. The RNA level of mitogen-activated protein kinase kinase 1 (MAP2K1) was downregulated by miR-330-3p in liver cancer cells. In conclusion, miR-330-3p suppresses cell migration by targeting MAP2K1 in liver cancer cells.
微小RNA被认为是肿瘤治疗的一个有前景的研究重点,是大量基因的关键调节因子。本研究的目的是探讨微小RNA(miR)-330-3p在肝癌中的生物学功能,因为先前已发现miR-330-3p在肝癌中表达失调。为了确定miR-330-3p在肝癌中的功能,采用逆转录-定量聚合酶链反应分析方法检测肝癌组织及癌旁非肿瘤组织中miR-330-3p的表达。为了阐明miR-330-3p在肝癌中的功能,通过模拟转染使miR-330-3p过表达。miR-330-3p抑制肝癌细胞的迁移。利用微小RNA靶标预测数据库鉴定肝癌中miR-330-3p的潜在靶基因。在肝癌细胞中,miR-330-3p下调丝裂原活化蛋白激酶激酶1(MAP2K1)的RNA水平。总之,miR-330-3p通过靶向肝癌细胞中的MAP2K1抑制细胞迁移。